Novel Technologies in Plasma Fractionation. Dieter Fassnacht
|
|
- Amberly Oliver
- 6 years ago
- Views:
Transcription
1 Novel Technologies in Plasma Fractionation Dieter Fassnacht
2 Agenda Grifols Overview Grifols Engineering Innovations in - Pooling - Fractionation - Filling Developing new technologies to provide innovative solutions is a core value to Grifols Grifols Therapeutics Plant in Clayton, North Carolina, USA 2
3 Grifols Overview Grifols is the world s third largest producer of plasma derived medicines. 13,900 employees worldwide committed to serving patients affected by life-threatening conditions. Hospital Division Manufactures standard parental solutions, medical devices and logistics platforms for hospitals Diagnostics Division - Supplies industry with clinical analysis and laboratory testing tools. Produces analyzers, reagents, instrumentation and products to collect, process and store blood Bioscience Division - Treatment of medical conditions using blood components. Plasma collection and testing, manufacturing, marketing and sales, R&D Bioscience manufacturing sites are located in Parets del Vallès, Spain; Clayton, North Carolina and Los Angeles. Recent Acquisitions 2011: Grifols acquires Talecris Biotherapeutics for $ 3.4 billion 2014: Grifols acquires Novartis Diagnostics Unit for $ 1.7 billion 3 Stock Information New York: GRFS Madrid: GRF.MC
4 Grifols Engineering Developing new technologies and expertise to provide innovative solutions is a core value tor Grifols since founding of the company. Inheriting this spirit Grifols Engineering was established in 2001 to provide engineering solutions within the company but also to other pharmaceutical clients. External Experience Engineering projects include consulting, process engineering, feasibility studies, conceptual and detail design, construction and start-up services Machinery projects include specialized equipment for the fractionation industry, purification and fill lines. Plasma Fractionation Technology 1 COLLECTION 2 TESTING 3 POOLING 4 FRACTIONATION 5 PURIFICATION 6 FILLING 4
5 Pooling Combination of up to 11,000 frozen donations into single batch Challenges of Pooling Thawing and combination process needs to be fast to minimize loses in product yield Difficulties in opening and emptying containers to remove frozen plasma Plasma containers are either bottles or bags Open product needs to be handled in Class C Large amount of material handling (donations in, frozen product out, pallets and totes out, wastes out) 1 L Plasma Bottle 5 Traditional Approach Labor intensive manual process with bio-burden and injury risks. Thawing and recovery rate of each individual donation is highly inconsistent 0.5 L Plasma Bag
6 Automatic Bottle Opener Loading Side (Class D) 1. Manual Loading of Bottles 2. Skin-Thaw with Hot water 3. Rinse with AWFI 6 Unloading Side (Class C) 4. Air blow to dry bottles 5. Cutting station to open bottle Bottle lids are discarded into waste chute 6. Robot empties frozen plasma slugs into chute to vessel Detects failure to eject via weight change, then retry 7. Drip from empty bottles is collected for extra recovery 8. Empty bottles discarded into waste chute Loading side in Class D Unloading side in Class C (Level below contains Pooling vessels)
7 Plasma Bag Opener Method to skin-thaw is similar as for bottles Two parallel conveyers in single tunnel to increase throughput. Extended drying due to irregular bag shape Novel Plasma Bag Opener 1. Robot grabs bag and pulls it across stationary knife 2. Two rollers squeeze frozen plasma block out of plastic. 3. Camera system automatically detects unsuccessful discharge. Two parallel robots work independently to increase pooling rate 7
8 Semi-Continuous Pooling Minimization of residence time to increase cryoprecipitate yield Increase pooling rate to shorten process step Semi-continuous by starting product separation while still emptying plasma containers Vertical Facility Integration Empty bottles and caps fall to ground floor Frozen plasma fall via chute to horizontal thaw vessels on mezzanine below Pallet lifts to transport plasma from ground floor and return empty pallets and totes Plasma Freezer Plasma Lift Automatic Bottle Opener Pooling Vessel Waste 8
9 Fractionation Successive additions of ethanol and buffers and temperature changes as low as -7ºC precipitates certain protein fractions from the plasma. Proteins are then separated from the liquid via filtration or centrifugation Traditional Challenges in Fractionation Sub-freezing process requires -5ºC harsh work environment Open processing requires extensive clean-room areas Separation equipment (centrifuges or filter-presses) often requires manual cleaning Open handling of ethanol requires expensive electrical installations 9
10 Minimize Clean Room Space Move process equipment from clean room into technical space Improve cleanability of clean rooms Facilitate maintenance activities from non-clean room side Save construction cost and long term energy consumption Process Vessels Unique manway neck and inclined plane allow vessel installation in technical space 10
11 Minimize Clean Room Space Process Vessels Move vessels entirely into technical space Closed additions Permanent piping for CIP Aseptic sampling from instrument belt. Centrifuges Clean room only contains rotating bowl and paste collection vessel. Motor, belt drive, lift for paste collection unit above clean room ceiling Processing support skid in technical space behind clean room wall. 11
12 12 Minimize Cold Production Space Eliminate or reduce cold processing space Provide better work environment Improve cleanability of clean rooms Save construction cost and long term energy consumption Dual temperature rooms Room is maintained at +5ºC for standby, cleaning, equipment preparation Cool down to -7ºC takes about 2 hours and is initiated when required (e.g. harvest for filterpresses) Equipment innovations New centrifuge type does not require cold room. Product is fully enclosed and cooled via jacketed vessel
13 Maximize Use of Natural Light Increase natural lighting Provide more pleasant work environment Increase of glass facilitates communication between areas 13
14 North Fractionation Facility Key Figures Location: Clayton, NC, USA Size: 150,000 sq. ft. Project Cost: $ 343 million Construction Duration: 24 month FDA Licensure: November 2014 without pre-approval inspection! 14 Highlights Process: Plasma Fractionation through IV-1 paste Separation Technology: Centrifugation Capacity: up to 6 MML of plasma per year Batch size: 9,000 L (world s largest) Maximized closed processing and automation Minimized cold processing rooms and clean room space
15 North Fractionation Facility Expansion Key Figures Location: Clayton, NC, USA Size: 39,000 sq. ft. Project Cost: $ 28 million Construction Duration: 12 month FDA Licensure: November 2014 without pre-approval inspection! 15 Highlights Process: Fractionation from IV-4 to Albumin Separation Technology: Filtration Tied into NFF utilities, process support and gowning Optimal use of natural light Fast-track project executed in-house; engineering, project and construction management
16 Fractionament IV Key Figures Location: Parets del Valles, Spain Size: 1250 sq. m. footprint 3 stories Project Cost: 25 million Timeline Civil Works: Sep 2011 Jun 2012 Installation: May 2012 Jul 2013 Validation: Sept 2013 Jan 2014 EMA Licensure: May 2014 FDA Licensure: Dec Highlights Process: Plasma Fractionation through V paste Separation Technology: Centrifugation Capacity: up to 4 MML of plasma per year Batch size: 7,000 L Fast Track construction Minimized cold processing rooms and clean room space
17 Purification Purification processes in Plasma Fractionation start with intermediate pastes and use typical purification unit operations used throughout the biotech: Ultrafiltration Chromatography CIP Ultrafiltration Skid The fractionation industry has special requirements related to viral inactivation / removal steps which include: Solvent Detergent treatment Thermal inactivation Nanofiltration Nanofiltration System 17
18 Skid Design and Manufacturing Grifols as manufacturer of pharmaceuticals also designs and builds purifications skids in-house. Nanofiltration system 120 m2 Ultrafiltration Skid 18 Main advantages: Better cost, schedule and scope control Design experience remains within company Automation can be developed specific to manufacturing needs and software design experience greatly supports future troubleshooting Turn-over packages assembled for specific business needs to support for IOQ
19 Innovations in Filling Protective cap over stopper and vial guarantees sterility by providing labyrinth seal for microbes (principle of Pasteur flask). Cap is removed only seconds before actual fill and stoppering providing maximum protection. 19
20 Innovations in Filling Autoclave instead of depyrogenation oven provides decoupling of single equipment train to lessen impact of equipment failure allow staging of sterile vials before filling operation for fast product change-over Autoclaving fully assembled vials also provides easy sterilization of stopper Typical Filling Line Single continuous line Grifols Sterile Filling Line No separate stopper sterilization required Protective cap maximizes protection Decoupling of equipment Sterile staging for fast change-over 20
21 SFF Expansion Key Figures Location: Clayton, NC, USA Size: 23,000 sq. ft. Project Cost: $22 MM Construction Duration: 14 month FDA Licensure: Expected May 2016 Highlights Two new liquid fill lines Fast-Track project engineered and constructed inhouse Viewing corridor provides complete visibility to vial preparation and filling processes Novel design for Class A laminar flow recirculation 21
ENVIRONMENTAL PROGRAM
ENVIRONMENTAL PROGRAM 2017 2019 1 2 Specially protected biodiversity area, Clayton, North Carolina (Andrea Andersen) ENERGY INCREASE THE ENERGY EFFICIENCY OF EXISTING FACILITIES. REDUCE ELECTRICITY CONSUMPTION
More informationMONZA ST5 Project. Alberto Penati Patheon Monza EU Engineering Director. The world leader in serving science
MONZA ST5 Project Alberto Penati Patheon Monza EU Engineering Director The world leader in serving science SUMMARY 1. Monza Site Overview 2. Design Data 3. Philosophy and approach on installation 4. Challenges
More informationOverall progress in the third quarter of 2006
T H I R D Q U A R T E R R E P O R T 2 0 0 6 Overall progress in the third quarter of 2006 The third quarter of this financial year has shown very favorable growth in terms of the volume of Grifols business
More informationMicrobial contamination is a
B I O P R O C E S S TECHNICAL Barrier Vial Technology A Global Approach to the Aseptic Filling Process Diego López-Alvarez, Sergi Roura, and J.A. Garcia Microbial contamination is a concern and a constant
More informationOverall progress in the first quarter of 2007
F I R S T Q U A R T E R R E P O R T 2 0 0 7 Overall progress in the first quarter of 2007 Grifols has obtained a turnover of 181.8 million euros in the first quarter of the year, an increase of 20.4% compared
More informationA dedicated DSP plant for the production of ClairYg, a LFB liquid Immunoglobulin G preparation for intravenous use
A dedicated DSP plant for the production of ClairYg, a LFB liquid Immunoglobulin G preparation for intravenous use Christophe SEGARD Technical Director Industrial Exploitation LFB 1 1 Objectives of a new
More informationBioprocessing Challenges: High-Titer Mammalian-Based Cell Systems. Elements influencing the way Biologics may be manufactured /supplied in the future
Bioprocessing Challenges: High-Titer Mammalian-Based Cell Systems Jonathan Romero CMC Leadership, Technical Development Pharmaceutical Operations & Technology 2015 ISPE PRODUCT SHOW Business Drivers Elements
More informationLarge Scale Process Modules First in Place Technology. Detlef Kehm, PhD VP Site and Project Engineering April 24 th, 2013
Large Scale Process Modules First in Place Technology Detlef Kehm, PhD VP Site and Project Engineering April 24 th, 2013 Agenda Project Introduction Statistics, Design Objectives, Technology Considerations
More informationS E C O N D H A L F R E S U L T S
S E C O N D H A L F R E S U L T S 2 0 0 6 Flebogamma DIF had been approved by the FDA in December 2006. The product has several presentations. 2 G R I F O L S 2 0 0 6 General evolution of the year 2006
More informationDear shareholders, Víctor Grífols President and CEO of Grifols
ANNUAL 2012 REPORT Dear shareholders, Grifols ushered in a new era in 2012, one that has seen the company become the world s third-largest producer of plasma-derived medicines following the acquisition
More informationGrifols Net Profit Rises by 34.8% to 91 million Euros in the First Quarter of 2013
Page /7 Grifols achieves its highest quarterly sales revenue in absolute terms reaching 683.7 million euros and,6% growth Grifols Net Profit Rises by 34.8% to 9 million Euros in the First Quarter of 03
More informationNADERI ENGINEERING, INC.
BIO-PHARMACEUTICAL ENGINEERING & VALIDATION CAPABILITIES "Cost Effective Solutions Through Innovation" 1240 Powell Street, Suite 2-B Emeryville, CA 94608 Tel: (510) 547-4040 Fax: (510) 547-4141 Website:
More informationBHS-FILTRATION INC. BHS VACUUM BELT FILTER, CANDLE & PRESSURE PLATE FILTER TECHNOLOGIES FOR BIO-ENERGY APPLICATIONS
BHS-FILTRATION INC. BHS VACUUM BELT FILTER, CANDLE & PRESSURE PLATE FILTER TECHNOLOGIES FOR BIO-ENERGY APPLICATIONS 1. Crop Feedstocks for Bio-Ethanol 2. Cellulose Feedstocks for Bio-Ethanol 3. Wood Feedstocks
More informationGrifols net profit rises by 23% to million euros in the First Half of 2014
Grifols net profit rises by 23% to 224.8 million euros in the First Half of 2014 Growth and diversification drive revenues by 16.7% to 1,610.8 million euros. 75% of sales came from Bioscience Division
More information20bis, rue du chapitre ROQUEMAURE FRANCE Tel : Fax : Web :
20bis, rue du chapitre 30150 ROQUEMAURE FRANCE Tel : 003 466 82 82 60 Fax : 0033 466 90 21 10 Email : contact-info@celld.com Web : www.celld.com MedImmune MedImmune founded 1988 Targets: infectious diseases
More informationVetter Commercial Manufacturing
A unique blend of capabilities for aseptic fill and finish Vetter Commercial Manufacturing Delivering results across the production chain Answers that work 1 Manufacturing quality is just the beginning.
More informationBiotech Pharmaceutical Cosmeceutical Food. Modular System Design Valves, Pumps, Fittings Heat Exchangers
Biotech Pharmaceutical Cosmeceutical Food Modular System Design Valves, Pumps, Fittings Heat Exchangers CIP Systems Bio Waste Kill Systems Purification Systems Utility Process Modules Formulation Systems
More informationAutomated compounding for intravenous chemotherapy
Automated compounding for intravenous chemotherapy Not valid for printing! Low resolution PDF file. For high resolution files, please contact Communication & Image Dept. The correct preparation and administration
More informationSingle Use Bioreactor Scale up: Introduction of a 2000L SUB Equipment Train in 12 months
Single Use Bioreactor Scale up: Introduction of a 2000L SUB Equipment Train in 12 months Finesse CellWorld San Fransisco Claire Walsh BSc, MSc BioProcess Skills and Technology, Operations, Janssen Sciences
More informationThe Art of Clinical Supply Planning : Quality Product in the Right Place at the Right Time
The Art of Clinical Supply Planning : Quality Product in the Right Place at the Right Time Clinical Trial Supply Southeast 2015 July 15 th July 16 th RTP, North Carolina Presenters: Eva Allen Heather Phillips
More informationCSL s Large Scale Cell Culture Facility
BioProcess Network 20 th October 2011 CSL s Large Scale Cell Culture Facility Tim Hughes Sr. Dir. Clinical Manufacturing CSL Objective How to maximise the opportunity to build a state-of-theart facility
More informationA GUIDE TO BIOMANUFACTURING AT GENZYME
M A K I N G P R O T E I N T H E R A P I E S A GUIDE TO BIOMANUFACTURING AT GENZYME Genzyme strives to make a life-changing difference for patients with serious diseases by discovering, developing, and
More informationApplication of Disposable Technologies in Biopharmaceutical Manufacturing
BMD Summit, Disposables for Biopharm Production 13th December 2005 Reston, VA, USA Application of Disposable Technologies in Biopharmaceutical Manufacturing Martin Wrankmore, Continuous Improvement Lead,
More informationContract Manufacturing Services for Pre-filled Syringes
Contract Manufacturing Services for Pre-filled Syringes From Standard Solutions to Complex Products Stefan Czvitkovich, PhD Director Product Partnering Sterile Pharmaceuticals Central Europe CPhI woldwide
More informationThermo Scientific GeneJET Whole Blood RNA Purification Mini Kit #K0761
PRODUCT INFORMATION Thermo Scientific GeneJET Whole Blood RNA Purification Mini Kit #K0761 www.thermoscientific.com/onebio #K0761 Lot Exp. CERTIFICATE OF ANALYSIS Thermo Scientific GeneJET Whole Blood
More informationOn the Job Training (OJT) Skill Demo Sub-Curriculum. Knowledge Summit June 5-7, Philadelphia, PA
On the Job Training (OJT) Skill Demo Sub-Curriculum UL and the UL logo are trademarks of UL LLC 2013 Agenda Company Information Business Need Solution Implementation Results Conclusion 2 Grifols is a global
More informationAseptic Sampling Best Practices Endotoxin Binding Affinity
Aseptic Sampling Best Practices Endotoxin Binding Affinity Scope Technical Note This technical report describes a study to evaluate binding affinity of Control Standard Endotoxin (CSE) to different plastic
More informationSCHOTT Pharmaceutical Systems. adaptiq - ready-to-use vials for aseptic processing
SCHOTT Pharmaceutical Systems adaptiq - ready-to-use vials for aseptic processing Todays market trends require flexible filling concepts and pre sterilized (RTU) containers Targeted medicine e.g. Oncology
More informationThe Braine BioPilot An Integral Part of Bioprocess Development for Cell Culture- Based Biologics
The Braine BioPilot An Integral Part of Bioprocess Development for Cell Culture- Based Biologics Visit of Alabama Biotech Oct 2014 Alain BERNARD Vice President GPS, UCB Technical Operations Tech Ops BioTech
More informationContinuous Improvement of Prothrombinex-VF Manufacture
Continuous Improvement of Prothrombinex-VF Manufacture Owen Tatford Process Development Manager and John Lontos Fractionation Manager BPN Conference, Adelaide 2011 Prothrombinex-VF (PTX) A Prothrombin
More informationA MANUFACTURING PROCESS TO OBTAIN A HIGHLY-PURIFIED TRIPLE-SECURED FIBRINOGEN PRODUCT
A MANUFACTURING PROCESS TO OBTAIN A HIGHLY-PURIFIED TRIPLE-SECURED FIBRINOGEN PRODUCT Maduell P, Domingo N, López L, Gensana M, Caballero S, Belda P, Gajardo R, Grancha S, Ristol P R&D Area, Instituto
More informationSTERIS Continuous Effluent Decontamination (CED) System
LABORATORY RESEARCH STERIS Continuous Effluent Decontamination (CED) System The Safety and Efficacy of Continuous Effluent Decontamination A Breakthrough in Decontamination Technology Continuous Effluent
More informationVetter Development Service
A unique blend of expertise for clinical manufacturing Vetter Development Service Supporting your compound s success Answers that work 1 Your molecule s future starts here. By the time your new injectable
More informationGrifols net profit up by +6.2% to million euros and sales grow by +13.8% in the first quarter of 2015
Grifols net profit up by +6.2% to 128.5 million euros and sales grow by +13.8% in the first quarter of 2015 Income grows by +13.8% (+1.1% constant currency (cc) 1 ) to Euros 908.4 million, driven by sales
More informationEconomic Impact of Single-Use Bioreactors
Economic Impact of Single-Use Bioreactors Rick Stock 2012 BIO International Convention BioProcess Theater Presentation Upstream Processing Boston, MA June 19th, 2012 BioProcess Technology Consultants www.bptc.com
More informationHuman Protein Process Sciences, Lille, France 2. Shabrawishi Hospital Blood Bank, Cairo, Egypt 3. University of Saskatoon, Canada
1 Human Protein Process Sciences, Lille, France 2 Shabrawishi Hospital Blood Bank, Cairo, Egypt 3 University of Saskatoon, Canada Why such a concept? Non-virally inactivated plasma components are still
More informationFinal Bottling Filtration. Nate Starbard Gusmer Enterprises
Final Bottling Filtration Nate Starbard Gusmer Enterprises Final Bottling Filtration The final bottling filtration is the only and ultimate guarantee for a finished wine s quality and stability Integrity
More informationPlasma Fractionation Today and in the Future Plasma Product Biotechnology Meeting
Plasma Fractionation Today and in the Future 2013 Plasma Product Biotechnology Meeting 1 What we do matters Dayna and her husband, Brian, are the parents of four wonderful, amazing children, Charlie, Kate,
More informationVirus Safety in Plasma- Derived Therapeutics: A Merck Perspective. IPFA Yogyakarta, March Louis Wong
Virus Safety in Plasma- Derived Therapeutics: A Merck Perspective IPFA Yogyakarta, March 2017 Louis Wong Associate director, Plasma Initiative, Asia-Pacific Content Regulatory Expectations for Plasma-Derived
More informationNew technologies in biopharmaceutical processes BioTech Vaccines Plasma
New technologies in biopharmaceutical processes BioTech Vaccines Plasma Dominik Arnold dominik_arnold@pall.com Challenges in Down Stream Processing Higher. Titers >4 g/l Yield > 90% Protein concentration
More informationDEAR SHAREHOLDERS, I would like to end by thanking everyone, once again, for the trust they have placed in our management of the company.
ANNUAL 2015 REPORT DEAR SHAREHOLDERS, Before reviewing our results for 2015, I would like to take a moment to recall that this year also saw us celebrate our 75th anniversary: three quarters of a century
More informationConsumer Healthcare. Processing OTC, diagnostic products and health supplements
Consumer Healthcare Processing OTC, diagnostic products and health supplements Faster, better, further: Best equipped for Consumer Healthcare Machine concepts for the healthcare market Nowadays people
More informationNeural Stem Cells (ipsc from Blood Cells; Male)
Applied StemCell, Inc. (866) 497-4180 www.appliedstemcell.com Datasheet Neural Stem Cells (ipsc from Blood Cells; Male) Product Information Catalog Number ASE-9234 (Male) Description Applied StemCell's
More informationPresentation Title Author Name
Presentation Title Author Name 1 An Introduction to West Pharmaceutical Services: West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable
More information2008 SECOND HALF REPORT
2008 SECOND HALF REPORT Net Profit totalled 121.7 MM euros, up 38.7 % on the previous year Revenue rose 15.8%to 814.3 MM euros EBITDA advanced 32.8% to 236.2 MM euros, with an EBITDA margin of 29.0% Grifols
More informationIntroduction and Background
Introduction and Background Validation of Biotech Facilities Pacific Biotech Alliance Robert J. Mackey Pacific Biotech Alliance is an established consulting firm in the Pacific Northwest that specializes
More informationGrifols achieves a record net profit of million euros with growth of 36.1% in 2014
Grifols achieves a record net profit of 470.3 million euros with growth of 36.1% in 2014 Grifols net revenues rose by 22.4% to 3,355.4 million euros EBITDA exceeds 1 billion euros for the first time: 21.1%
More informationGrifols sales increase by 15.2% 1 to 1,316.7 million euros in the first half of 2012
Sales in Spain, Italy, Portugal and Greece represented approximately 13% of global revenues Grifols sales increase by 15.2% 1 to 1,316.7 million euros in the first half of 2012 Following the integration
More informationSMART PWD ASEPTIC POWDER FILLING AND STOPPERING MACHINE
SMART PWD ASEPTIC POWDER FILLING AND STOPPERING MACHINE SMART PWD ASEPTIC POWDER FILLING & STOPPERING MACHINE THANKS TO INTELLIGENT SERVO TECHNOLOGY, THE MACHINE IS EXTREMELY USER-FRIENDLY AND FLEXIBLE
More informationYour benefit is our incentive
MULTIVAC product overview Packaging solutions with method. 2 Your benefit is our incentive MULTIVAC stands for Better Packaging. But what lies behind these two words? As a benefactor of packaging solutions
More informationScale-Up Case Study for Long Term Storage of a Process Intermediate in Bags
Weidner_APR 7/10/08 8:33 AM Page 1 Scale-Up Case Study for Long Term Storage of a Process Intermediate in Bags Jim Weidner, Dr. Franqui Jimenez Amgen Summary Ascalable frozen process intermediate step
More informationPart III MATERIAL HANDLING AND IDENTIFICATION TECHNOLOGIES
Part III MATERIAL HANDLING AND IDENTIFICATION TECHNOLOGIES Chapters: 10.Material Transport Systems 11.Storage Systems 12.Automatic Identification and Data Capture Material Handling Technologies in the
More informationHuman IL-6 ELISA Set
Human IL-6 ELISA Set Catalog No. CDK082B Quantity: 10 x 96 tests PRODUCT SPECIFICATIONS : Specificity: Recognizes both natural and recombinant human IL-6 Range: 6.25 pg / ml - 200 pg / ml Sensitivity:
More informationApplication of Single-Use Equipment for Buffer Storage and Distribution in Medium Size mab Production Facility
Reprinted from PHARMACEUTICAL ENGINEERING THE OFFICIAL TECHNICAL MAGAZINE OF ISPE JANUARY/FEBRUARY 2014, VOL 34, NO 1 Copyright ISPE 2014 www.pharmaceuticalengineering.org facilities and equipment Application
More informationFor sterile products manufacturing, Lyoseal is an innovative technology. presented by Mr. Tony Bouzerar from BioCorp offers us detailed
For sterile products manufacturing, Lyoseal is an innovative technology to improve quality problems with final drug product due to crimping issues and inadequate stopper seating. It eliminates aluminum
More informationFlow-Rail Pallet Storage System
Flow-Rail Pallet Storage System Flow-Rail is a high-density pallet storage system operated using conventional fork-lift trucks. It is a non-motorized, last-in/first-out system that can hold from 3 up to
More informationUser Manual. OriCell TM Mesenchymal Stem Cell Osteogenic Differentiation Medium. Cat. No. GUXMX-90021
User Manual OriCell TM Mesenchymal Stem Cell Osteogenic Differentiation Cat. No. GUXMX-90021 PRODUCT DESCRIPTION: OriCell TM Mesenchymal Stem Cell Osteogenic Differentiation consists of optimized Mesenchymal
More informationActavis Italy. Nerviano Plant
Actavis Italy Nerviano Plant Starting out in 1901 in Jerusalem The company known today as Teva was established as a small wholesale drug business by Chaim Salomon, Moshe Levin and Yitschak Elstein. (They
More informationDepyrogenation Oven. depyrogenation and dry heat sterilization
Depyrogenation Oven depyrogenation and dry heat sterilization Lytzen philosophy The philosophy behind the Lytzen Depyrogenation ovens is never to compromize on our high level of quality in every detail.
More informationThe World Health Assembly Resolution on availability, safety and quality of blood products (WHA 63.12) Adopted May 2010
The World Health Assembly Resolution on availability, safety and quality of blood products (WHA 63.12) Adopted May 2010 Dr Ana Padilla Blood Products & related Biologicals Essential Medicines and Pharmaceutical
More informationHuman IL-1 alpha ELISA Kit
Human IL-1 alpha ELISA Kit Catalog No: CDK025B Quantity: 2 x 96 tests SPECIFICITY : RANGE : SENSITIVITY : INCUBATION : SAMPLE TYPES : Recognizes both natural and recombinant human IL-1 alpha 31.2 pg /
More informationAllergy Laboratories, Inc. 10/4/13
Allergy Laboratories, Inc. 10/4/13 SEP 04, 2013 Department of Health and Human Services Public Health Service Food and Drug Administration Office of Regulatory Affairs 12420 Parklawn Drive ELEM-2152 Rockville,
More information+91-8048762858 Servo Enterprisess http://www.servoenterprisess.com/ Servo Enterprisess is a leading manufacturer & exporter of Industrial & Scientific Laboratory Equipments. We offer a wide range of products
More information96 well Plant Genomic DNA Purification Kit
96 well Plant Genomic DNA Purification Kit Cat. #: DP022-9602/ DP022-9608 Size: 2 x 96 / 8 x 96 Reactions Store at RT For Research Use Only 2015.10.08 1 Description : The 96 well Plant Genomic DNA Purification
More informationFuture biologics manufacturing
Future biologics manufacturing Process integration with single-use technology Dr. Günter Jagschies Senior Director, Strategic Customer Relations GE Healthcare Life Sciences Uppsala, Sweden Mammalian Cell
More informationHandling solutions for sterilised products / End of Line automation
Handling solutions for sterilised products / End of Line automation 1 Lan Abar Handling Technologies Founded in 1970 Located in Tilburg & Halfweg, the Netherlands A team of 110 people Turnkey solutions
More informationScalable Strategies for Parenteral Dosage Form Selection
Scalable Strategies for Parenteral Dosage Form Selection Tony Pidgeon Process Technology Director Pharma Services Patheon, part of Thermo Fisher Scientific There are many parenteral dosage forms from which
More informationcontent. Diced fruits. Formula based products. Fruit pulp. Creams. Gazpachos.
ASEPTIC MONOBLOCKS Gémina monoblocks are the ideal solution for small and medium production processes. They consists on the integration of an aseptic filler machine and a pasteurisation plant, hence creating
More informationSpecial format labels have been available for many years now, appearing in a variety of different industries most notably chemical, cosmetic,
Special format labels have been available for many years now, appearing in a variety of different industries most notably chemical, cosmetic, healthcare and pharmaceutical. Dual and multi layer labels
More informationHISTORY AND MILESTONES
HISTORY AND MILESTONES HISTORY AND MILESTONES DOC S.r.l., Documentation Organization & Consultancy, was established in 1997 by MASCO group C.E.O. Eng. Alberto Borella and Eng. Paolo Curtò who became Managing
More informationGrifols sales rose by 4.6% to Euros 2,741.7 million in 2013
Grifols sales rose by 4.6% to Euros 2,741.7 million in 2013 Bioscience leads the growth with +5.3% (+8.2% cc 1 ) sales increase driven by volume growth in all plasma derivative products and stable prices.
More informationGrifols net profit increases by 26.9% to 339 million euros in the nine months to September 2014
Grifols net profit increases by 26.9% to 339 million euros in the nine months to September 2014 Revenues rose by 19.1% reaching 2,438.1 million euros to september 2014. Grifols growth accelerates 24.5%
More informationTHIRD QUARTER 2014 REPORT
THIRD QUARTER 2014 REPORT DISCLAIMER The facts and figures contained in this report which do not refer to historical data are projections and forwardlooking statements. The words and expressions like believe,
More informationManual innuprep Micro RNA Kit
Manual Order No.: 845-KS-2030010 10 reactions 845-KS-2030050 50 reactions 845-KS-2030250 250 reactions Publication No.: HB_KS-2030_e_120116 This documentation describes the state at the time of publishing.
More informationCritical Environment Products and Services
Critical Environment Products and Services For over two decades, EP Scientific products and services have defined clean for environmental sampling containers and services. Our proprietary cleaning methods
More informationExamples of plant layout and design
Examples of plant layout and design Principles of plant layout and design will apply to most industrial situations. The following layout examples encompass a wide variety of facility characteristics, and
More informations c r e w - c a p p i n g s e a l i n g p u s h - o n c a p p i n g HIGH-PERFORMANCE CAPPING Custom-designed machines to suit your applications
s c r e w - c a p p i n g s e a l i n g p u s h - o n c a p p i n g HIGH-PERFORMANCE CAPPING Custom-designed machines to suit your applications Scope Zalkin Signature Capping High quality dedicated to
More informationINSPECTION OF BIOTECHNOLOGY MANUFACTURES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 024-2 25 September 2007 AIDE-MEMOIRES INSPECTION OF BIOTECHNOLOGY MANUFACTURES PIC/S September 2007 Reproduction prohibited
More informationOverview of Inspection Issues with Legacy Products. Barbara Breithaupt Consumer Safety Officer
Overview of Inspection Issues with Legacy Products Barbara Breithaupt Consumer Safety Officer 1 Overview of the presentation The role of the Quality Unit will be discussed in the context of the inspection
More informationVetter Development Service
A unique blend of expertise for clinical manufacturing Vetter Development Service Supporting your compound s success Answers that work 1 Your molecule s future starts here. By the time your new injectable
More informationTMI-Orion Pharmaceutical Medical
INDUSTRY FLYER TMI-Orion Pharmaceutical Medical HIGH TECH DATA LOGGING SOLUTIONS www.tmi-orion.com TMI-Orion Pharmaceutical Medical TMI-Orion presents a full range of high tech data loggers designed for
More informationTMI-Orion Pharmaceutical Medical
INDUSTRY FLYER TMI-Orion Pharmaceutical Medical HIGH TECH DATA LOGGING SOLUTIONS www.tmi-orion.com TMI-Orion Pharmaceutical Medical TMI-Orion presents a full range of high tech data loggers designed for
More informationArtificial Intelligence
Artificial Intelligence 2018 PROGRAM CAIS (Can Mold AI Solutions) a Division of Pet All Manufacturing Inc. 85 Royal Crest Court. Unit 1-2 Markham, ON Canada L3R 9X5 407 S 107 th Ave. Unit 10 Tolleson,
More informationDavid Schneider Hänel Storage Systems Presented by: Tim Archer Kardex Remstar Joseph Elie MODULA. Sponsored by:
Sponsored by: David Schneider Hänel Storage Systems Presented by: Tim Archer Kardex Remstar Joseph Elie MODULA 2015 MHI Copyright claimed for audiovisual works and sound recordings of seminar sessions.
More informationReview Validation of aseptic processes for pharmaceuticals
OPEM www.opem.org Oriental Pharmacy and Experimental Medicine 2010 10(4), 231-238 DOI 10.3742/OPEM.2010.10.4.231 Review Validation of aseptic processes for pharmaceuticals Lincy Joseph*, Mathew George
More informationENGINEERING CHALLENGES FROM THE LAB TO FACILITY
ENGINEERING CHALLENGES IN SCALING PURIFICATION FROM THE LAB TO FACILITY Christian Lim, Process Engineer CRB (Clark, Richardson, & Biskup) Consulting Engineers Boston, MA 10-May-2012 Topics Introduction
More informationPorcine Interleukin 1 Beta(IL-1β) ELISA Kit
Porcine Interleukin 1 Beta(IL-1β) ELISA Kit Cat.No: DEIA-T6104 Lot. No. (See product label) Size 96T Intended Use The Porcine Interleukin 1 Beta(IL-1β) ELISA Kit is to be used for the vitro quantitative
More informationIntroduction. Principle
Contents Introduction............................................................ 2 Principle.............................................................. 2 Storage and Stability.....................................................
More informationWelcome Biotech 101. Outline. Before the Floor. Manufacturing Process. Supporting Cast 4/22/2013
Welcome Biotech 101 Outline Before the Floor All the activities that happen before large scale cgmp manufacturing Manufacturing Process Manufacturing steps Equipment Requirements How it all works together
More informationSOP: PP003.2 Modified: 6/10/2010 Large-scale growth of Mycobacterium tuberculosis
SOP: PP003.2 Modified: 6/10/2010 Large-scale growth of Mycobacterium tuberculosis Materials and Reagents: 1. Biosafety cabinet (BSC) 2. Three 100 ml frozen stocks of M. tuberculosis (see SOP PP002) 3.
More informationVibro a unique filtration device for micro- and ultrafiltration
Vibro a unique filtration device for micro- and ultrafiltration Vibro is the perfect filtration solution for process development and industrial filtration applications where low energy consumption, high
More informationCell Therapy Services Your Product. Our Passion.
Pharma&Biotech Cell Therapy Services Your Product. Our Passion. Complete Portfolio of Services for cgmp Manufacturing of Cell-based Products Pharma&Biotech Cell Therapy Services for cgmp Manufacturing
More informationProfessionals in Process /Product Technologies
Professionals in Process /Product Technologies We are Professionals in Process/ Product Technologies with following expertise- Conceptualization and Engineering of Projects Module and skid building Custom-built
More informationSingle-Use Final Fill: Benefits and Considerations
Single-Use Final Fill: Benefits and Considerations TENDÊNCIAS DE TECNOLOGIAS DE FABRICAÇÃO E ASSÉPTICA DE MEDICAMENTOS Ana Luísa Lampert Cadore Sales Specialist SU & Aseptic Process Solutions ana.cadore@merckgroup.com
More informationObjectives. Citations. Model: Establishment Inspection
Objectives Biotechnology Derived Therapeutics Virtual Tour 3-April-2006 Pharm523 Survey of Biomedical Regulatory Affairs see BDT manufacturing stuff in a flow chart context Consider conjunction of manufacturing
More informationFS 1000/3000 SIP BIOREACTORS/FERMENTORS FOR INDUSTRIAL PROCESSES
FS 1000/3000 SIP BIOREACTORS/FERMENTORS FOR INDUSTRIAL PROCESSES THE COMPANY Bionet is a specialist in bioprocesses engineering. We provide equipment (Bioreactors, Cross-Flow Filtration Systems and Cleaning-In-Place
More informationAFFINITY HIS-TAG PURIFICATION
DESCRIPTION Resins are products that allow batch or column purifications. This product is supplied as a suspension in 50% aqueous suspension containing 30 vol % ethanol. INSTRUCTIONS The resins are adapted
More informationChain Driven Live Roller Conveyor (CDLR) Activated Roller Belt. Ball Transfer Tables. Chain Transfers. Continuous and Reciprocating Vertical Conveyor
Activated Roller Belt Ball Transfer Tables Belt Conveyor Quickly rotates multiple package types using stationary or retractable bump turn Aligns packages quickly and positively for applications like print
More informationValidation Master Plan
Master Plan TITLE: SITE VALIDATION MASTER PLAN 2001 Quality Assurance Document No. XXXXX Rev.no. Page 1 of 15 Subject of Latest Revision: - CONTENTS 1. INTRODUCTION 2. OBJECTIVE 3. DEFINITIONS 4. SCOPE
More informationHot Topics in Drug Product Process Validation: A Reviewer s Perspective
Hot Topics in Drug Product Process Validation: A Reviewer s Perspective Colleen Thomas, Ph.D. Quality Assessment Lead (Acting) FDA/CDER/OPQ/OPF Division of Microbiology Assessment CASSS CMC Strategy Forum
More information